Department of Neurosciences, IRCCS Mario Negri Institute for Pharmacological Research, Milano, Italy.
Epilepsia. 2014 Jul;55(7):963-7. doi: 10.1111/epi.12579. Epub 2014 Jun 25.
The incidence, prevalence, and mortality of epilepsy vary across countries with different economies. Differences can be explained by methodological problems, premature mortality, seizure remission, socioeconomic factors, and stigma. Diagnostic misclassification-one possible explanation-may result from inclusion of patients with acute symptomatic or isolated unprovoked seizures. Other sources of bias include age and ethnic origin of the target population, definitions of epilepsy, retrospective versus prospective ascertainment, sources of cases, and experienced and perceived stigma. Premature mortality is an issue in low-income countries (LICs), where treatment gap, brain infections, and traumatic brain injuries are more common than in high-income countries (HICs). Death rates may reflect untreated continued seizures or inclusion of acute symptomatic seizures. Lack of compliance with antiepileptic drugs has been associated with increased risk for death, increased hospital admissions, motor vehicle accidents, and fractures in poor communities. Epilepsy is a self-remitting clinical condition in up to 50% of cases. Studies in untreated individuals from LICs have shown that the proportion of remissions overlaps that of countries where patients receive treatment. When the identification of patients is based on spontaneous reports (e.g., door-to-door surveys), patients in remission may be less likely to disclose the disease for fear of stigmatization with no concurrent benefits. This might lead to underascertainment of cases when assessing the lifetime prevalence of epilepsy. In LICs, the proportion of people living in poverty is greater than in HICs. Poverty is associated with risk factors for epilepsy, risk for developing epilepsy, and increased mortality. The high incidence and prevalence of epilepsy found in LICs is also observed in low income individuals from HICs. Epileptogenic conditions are associated with an increased mortality. This may partly explain the difference between incidence and lifetime prevalence of epilepsy in LICs. Poverty within LICs and HICs could be a preventable cause of mortality in epilepsy.
癫痫的发病率、患病率和死亡率因经济水平不同的国家而异。这种差异可以用方法学问题、过早死亡、癫痫缓解、社会经济因素和耻辱感来解释。诊断错误分类是可能的原因之一,可能是由于包括急性症状性或孤立性无诱因发作的患者。其他偏倚来源包括目标人群的年龄和种族、癫痫的定义、回顾性与前瞻性确定、病例来源以及经验和感知的耻辱感。过早死亡是低收入国家(LICs)的一个问题,在这些国家,治疗差距、脑部感染和创伤性脑损伤比高收入国家(HICs)更为常见。死亡率可能反映了未经治疗的持续发作或包括急性症状性发作。在贫困社区,不遵守抗癫痫药物治疗与死亡风险增加、住院次数增加、机动车事故和骨折有关。癫痫在多达 50%的病例中是一种自限性临床疾病。来自 LICs 的未治疗个体的研究表明,缓解的比例与接受治疗的国家相似。当患者的识别基于自发报告(例如,挨家挨户调查)时,缓解期的患者由于害怕被污名化而不太可能披露疾病,而没有任何伴随的好处。这可能导致在评估癫痫终生患病率时,病例的确定不足。在 LICs 中,生活在贫困中的人口比例高于 HICs。贫困与癫痫的危险因素、癫痫发病风险和死亡率增加有关。在 LICs 中发现的癫痫高发病率和高患病率也见于 HICs 的低收入个体。致痫性疾病与死亡率增加有关。这可能部分解释了 LICs 中癫痫发病率和终生患病率之间的差异。LICs 和 HICs 中的贫困可能是癫痫死亡的一个可预防原因。
Epilepsia. 2014-6-25
Epilepsia. 2014-6-25
Inj Control Saf Promot. 2003
Ment Retard Dev Disabil Res Rev. 2002
Neuroepidemiology. 2020
Curr Opin Neurol. 2003-4
Front Epidemiol. 2022-8-1
Nutrients. 2022-11-24